Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02568046 · ClinicalTrials.gov registry record · Phase 1
Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients
A Phase 1 study, sponsored by Symphogen A/S.
- Terminated
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT02568046: Clinical Trial Phase 1 study, sponsored by Symphogen A/S.
NCT02568046 is a Phase 1 study that was terminated before completion, run by Symphogen A/S. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02568046, a Phase 1 study, was terminated before completion, sponsored by Symphogen A/S.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a Phase 1b/2a study investigating the safety and efficacy of Sym004, an investigational medicinal product (IMP), in combination with FOLFIRI (chemotherapy) when administered every second week (Q2W).
Primary Outcome
AEs were coded according to the Medical Dictionary for Regulatory Activities (MedDRA) classification. The incidence and type of AEs (e.g., treatment-emergent AE \[TEAE\]) were summarized according to MedDRA system organ classes and preferred terms. An AE was considered as treatment-emergent if it occurred after the first treatment administration.
Interventions
- DRUG FOLFIRI
- DRUG Sym004
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-03-15 |
| Est. Completion | 2018-05-05 |
| Phase | Phase 1 |
Why NCT02568046 stopped before completion
NCT02568046 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which FOLFIRI is the first listed.
NCT02568046 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02568046 about?
NCT02568046 is a clinical study titled "Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients". This is a Phase 1b/2a study investigating the safety and efficacy of Sym004, an investigational medicinal product (IMP), in combination with FOLFIRI (chemotherapy) when administered every second week (Q2W).
What is the current status of trial NCT02568046?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2016-03-15. Estimated completion is 2018-05-05.
What interventions are being tested in trial NCT02568046?
The interventions under investigation include: FOLFIRI (DRUG), Sym004 (DRUG).
Who is sponsoring clinical trial NCT02568046?
This trial is sponsored by Symphogen A/S, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02568046's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI